BC Mental Health and Addictions Research Institute
SEARCH
-
CONTACT US

Publications - Ric Procyshyn

2006/07 to 2010/11

Barr, A. M., Honer, W. G., Johnson, J. L., Wu, T. K., & Procyshyn, R. M. (2010). A comparison of antipsychotic drug-defined daily doses versus chlorpromazine equivalent doses in patients with or without extrapyramidal motor symptoms. Journal of Clinical Psychopharmacology, 30(6), 741-743.

Procyshyn, R.M., & Barr, A.M. (2010). Insomnia. In: C. Repchinsky (Ed.). Patient Self-Care: Helping patients make therapeutic choices, (2nd Ed.). Ottawa, ON: Canadian Pharmacists Association.

Procyshyn, R.M. (2010). Depression. In: C. Repchinsky (Ed.). Patient Self-Care: Helping patients make therapeutic choices, (2nd Ed.). Ottawa, ON: Canadian Pharmacists Association.

Procyshyn, R. M., Honer, W. G., Wu, T. K., Ko, R. W., McIsaac, S. A., Young, A. H., Johnson, J.L., & Barr, A. M. (2010). Persistent antipsychotic polypharmacy and excessive dosing in the community psychiatric treatment setting: A review of medication profiles in 435 canadian outpatients. The Journal of Clinical Psychiatry, 71(5), 566-573.

Procyshyn, R. M., Barr, A. M., Flynn, S., Schenk, C., Ganesan, S., & Honer, W. G. (2010). Long-acting injectable risperidone in treatment refractory patients: A 14-week open-label pilot study. Schizophrenia Research, 123(2-3), 273-275.

Procyshyn, R. M., Barr, A. M., Brickell, T., & Honer, W. G. (2010). Medication errors in psychiatry: A comprehensive review. CNS Drugs, 24(7), 595-609.

Okoli, C. T., Khara, M., Procyshyn, R. M., Johnson, J. L., Barr, A. M., & Greaves, L. (2010). Smoking cessation interventions among individuals in methadone maintenance: A brief review. Journal of Substance Abuse Treatment, 38(2), 191-199.

Lange, R. T., Brubacher, J. R., Iverson, G. L., Procyshyn, R. M., & Mitrovic, S. (2010). Differential effects of alcohol intoxication on S100B levels following traumatic brain injury. The Journal of Trauma, 68(5), 1065-1071.

Johnson, J. L., Ratner, P. A., Malchy, L. A., Okoli, C. T., Procyshyn, R. M., Bottorff, J. L., Groening, M., Schultz, A., & Osborne, M. (2010). Gender-specific profiles of tobacco use among non-institutionalized people with serious mental illness. BMC Psychiatry, 10, 101.

Boyda, H. N., Tse, L., Procyshyn, R. M., Wong, D., Wu, T. K., Pang, C. C., & Barr, A. M. (2010). A parametric study of the acute effects of antipsychotic drugs on glucose sensitivity in an animal model. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 34(6), 945-954.

Boyda, H. N., Tse, L., Procyshyn, R. M., Honer, W. G., & Barr, A. M. (2010). Preclinical models of antipsychotic drug-induced metabolic side effects. Trends in Pharmacological Sciences, 31(10), 484-497.

Procyshyn, R. M., Honer, W. G., & Barr, A. M. (2009). Do serum lipids predict response to clozapine treatment? Journal of Psychiatry & Neuroscience : JPN, 34(2), 168.

JJohnson, J. L., Malchy, L. A., Ratner, P. A., Hossain, S., Procyshyn, R. M., Bottorff, J. L., Groening, M., Gibson, P., Osborne, M., & Schultz, A. (2009). Community mental healthcare providers' attitudes and practices related to smoking cessation interventions for people living with severe mental illness. Patient Education and Counseling, 77(2), 289-295.

Honer, W. G., Procyshyn, R. M., Chen, E. Y., MacEwan, G. W., & Barr, A. M. (2009). A translational research approach to poor treatment response in patients with schizophrenia: Clozapine-antipsychotic polypharmacy. Journal of Psychiatry & Neuroscience : JPN, 34(6), 433-442.

Ganesan, S., Taylor, R., Rabheru, K., Forbes, I., Dumontet, J., & Procyshyn, R. M. (2008). Antipsychotic polypharmacy does not increase the risk for side effects. Schizophrenia Research, 98(1-3), 323-324.

Barr, A. M., Procyshyn, R. M., Hui, P., Johnson, J. L., & Honer, W. G. (2008). Self-reported motivation to smoke in schizophrenia is related to antipsychotic drug treatment. Schizophrenia Research, 100(1-3), 252-260

Procyshyn, R. M., Wasan, K. M., Thornton, A. E., Barr, A. M., Chen, E. Y., Pomarol-Clotet, E., Stip, E., Williams, R., MacEwan, G.W, Birmingham, C.L., & The Clozapine and Risperidone Enhancement Study Group. (2007). Changes in serum lipids, independent of weight, are associated with changes in symptoms during long-term clozapine treatment. Journal of Psychiatry & Neuroscience : JPN, 32(5), 331-338.

Dumontet, J., Malyuk, R., Kiang, G., & Procyshyn, R. M. (2006). Corrected QT intervals in newly admitted geriatric psychiatric patients: An examination of risk factors. Canadian Journal of Psychiatry, 51(6), 371-376.